Opinion

Video

Advancing CML Management Towards an Ideal Patient Journey

Author(s):

Jorge E. Cortes, MD,Joannie Clements

The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      This program was made possible with support from Novartis Pharmaceuticals.

      Video content above is prompted by the following:

      • What are the biggest unmet needs you see for CML patients today, and how do you think emerging therapies and research could address those gaps in the future?
      • What excites you most about the potential advancements in CML management that may be on the horizon in the next 5-10 years?
      • How do you envision the CML patient experience being transformed compared to today?

      Newsletter

      Stay up to date on cancer updates, research and education

      Subscribe Now!
      Related Videos
      Image of Dr. Christopher R. Flowers.
      Minimal Residual Disease Testing’s Variability Across Cancer Types
      The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
      The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
      Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors
      Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors
      Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs
      Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs
      CLL Treatment and Quality of Life: Patient Empowerment and Shared Decision-making
      CLL Treatment and Quality of Life: Patient Empowerment and Shared Decision-making
      LL Treatment Roadmap: Navigating First-Line Options With Your Doctor
      LL Treatment Roadmap: Navigating First-Line Options With Your Doctor
      Watchful Waiting in CLL: When Waiting Is Treating
      Watchful Waiting in CLL: When Waiting Is Treating
      Image of a woman with brown wavy hair, wearing a navy blue top.
      What to Expect With a Stem Cell Transplant for Leukemia
      Connections: CLL Diagnosis: A Patient’s Perspective and Physician Insights
      Connections: CLL Diagnosis: A Patient’s Perspective and Physician Insights
      Connections: Understanding CLL: Symptoms, Diagnosis, and What Patients Need to Know
      Connections: Understanding CLL: Symptoms, Diagnosis, and What Patients Need to Know
      Related Content
      Site Logo
      June 2nd 2023

      Georgia Cancer Center installs sunscreen dispensers across Augusta University campuses

      What Is CAR-T Cell Therapy, and What Can Patients With Cancer Expect?
      September 16th 2022

      What Is CAR-T Cell Therapy, and What Can Patients With Cancer Expect?

      Brielle Benyon
      Over the past five years, CAR-T cell therapy has improved outcomes for many patients with blood cancer. Here’s what patients need to know about the immune-based treatment.
      The 'Flipside' of Tumor Lysis Syndrome Shows Efficacy in Leukemia, Lymphoma
      August 11th 2022

      The 'Flipside' of Tumor Lysis Syndrome Shows Efficacy in Leukemia, Lymphoma

      Andy Polhamus
      Although tumor lysis syndrome may be dangerous and fatal if not treated early, experts note that it is a sign of successful treatment in patients with leukemia and lymphoma.
      FDA OKs Continued Enrollment in Ongoing Blood Cancer Clinical Trials After Gilead Addresses Safety Concerns
      April 15th 2022

      FDA OKs Continued Enrollment in Ongoing Blood Cancer Clinical Trials After Gilead Addresses Safety Concerns

      Brielle Benyon
      Earlier in the year, clinical trials assessing magrolimab for myelodysplastic syndrome and acute myeloid leukemia were put on a partial clinical hold, but now the FDA said that they can start enrolling patients again.
      New Treatments Lend a Positive Outlook to Patients With GVHD
      February 28th 2022

      New Treatments Lend a Positive Outlook to Patients With GVHD

      Brielle Benyon
      There are now more drugs than ever to treat and prevent graft-versus-host disease in patients with blood cancer who receive a stem cell transplant.
      Trial Initiated to Study Protein-Inhibiting Treatment Option for Patients With Acute Leukemia
      February 17th 2022

      Trial Initiated to Study Protein-Inhibiting Treatment Option for Patients With Acute Leukemia

      Jamie Cesanek
      A trial to examine BMF-219 in patients with relapsed or refractory acute leukemias has begun recruiting patients across multiple U.S. states.